Evaluation of Accuracy of Continuous Glucose Monitoring (CGM) in Patients With End Stage Renal Disease (ESRD) on Intermittent Hemodialysis (iHD).
Conditions: Diabetes; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 Intervention: Device: Continuous Glucose Monitor Sponsors: University of Virginia; DexCom, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials